We care about creating quality biologics with passion

We are developing the next generation of biosimilars to increase access to much needed therapies.

Polpharma Biologics

Developing the next generation of biosimilars

We are developing a portfolio of biosimilars to increase access to much needed therapies.

Our pipeline

We have developed an extensive and ever-growing pipeline of biosimilars to treat a number of conditions across major therapeutic areas.

Learn more
Our partnerships

We have partnered with some of the largest biopharmaceutical companies on the planet so our biosimilars can reach those that need them most.

Learn more
About biosimilars

Information on what biosimilars are, how they can improve patient access, how they go through clinical trials and how we develop them.

Learn more
Development & manufacturing capabilities

We have all the components to take biosimilars from concept to IND and clinical trials and to support global commercial supply.

Learn more

Join our team

All our staff are motivated by the same passion, getting safe and effective medicines to patients. Join us today.

Department -
Location Utrecht
Publication date 07/12/2021
Apply now
Department Technical Operations/ Operacje Techniczne
Location Duchnice (pow. warszawski zachodni)
Publication date 07/12/2021
Apply now
Department Other/ Inny
Location Gdańsk
Publication date 02/12/2021
Apply now

Our values

These are the values that we at Polpharma Biologics are guided by, help shape our decisions and drive us forward. We care about:

Creating quality biologics with passion

We are passionate about providing safe and effective medicines to patients.

Delivering on our commitments

We are self-motivated to reach the end result - “wait and see” is not in our vocabulary.

Being respectful and transparent

We are open and honest without exception.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

icon Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

icon Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

icon Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

  • Gdańsk
  • Warsaw - Duchnice
  • Utrecht
  • Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

  • Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

  • Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our team

At Polpharma Biologics, our commitment to excellence begins at the top. With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals. Our international management team brings both knowledge and passion to every project.

"It is here that new molecules, active substances and drugs for the largest companies in the world are created"

Next
Jerzy Starak

Founder and Owner, Polpharma Biologics Group

“We care about delivering on our commitments”

Next
Hannes Teissl

Vice Chairman, Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Dr Joerg Windisch

President & CEO, Polpharma Biologics Group

"We care about delivering on our commitments"

Next
Piotr Korycki

President, Polpharma Biologics Gdańsk & Managing Director, Polpharma Biologics Group

“We work with dedication and find innovative solutions”

Next
Frederic Papp

President, Polpharma Biologics Warsaw

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.